Anthracyclines Cause Endothelial Injury in Pediatric Cancer Patients: A Pilot Study
- 20 February 2006
- journal article
- treatment related-complications
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 24 (6), 925-928
- https://doi.org/10.1200/jco.2005.03.5956
Abstract
Purpose: The vascular endothelium plays a central role in the regulation of arterial vasomotor tone, releasing nitric oxide for vasodilation. Endothelial-dependent vasodilation can be assessed in vivo, using high resolution ultrasound to measure changes in diameter of the brachial artery. Animal studies have demonstrated that anthracyclines can damage the endothelium and impair the vasodilatory response of arteries; however, there are no comparable data in humans. This is a pilot study assessing endothelial toxicity from anthracyclines in pediatric cancer patients. Patients and Methods: Fourteen control patients and 14 cancer patients (4 to 21 years) were studied. Cancer patients had completed chemotherapy containing no less than 300 mg/m2 of anthracyclines 2 to 60 months before study. Brachial artery diameters were measured at rest and 1 minute after blood pressure cuff occlusion. Brachial artery reactivity (BAR) was calculated as percent change between baseline and after cuff deflation measurements. Results were compared using unpaired, two-tailed t-test. Results: Baseline characteristics, including age, percentage of females, blood pressure, and resting vessel diameters were similar between the two groups. BAR in the controls averaged 6.7% with a standard deviation (SD) of 3.3%, while BAR in patients receiving anthracyclines averaged 3.8% with an SD of 3.4%, demonstrating a significant decrease (P < .05) in vasomotor reactivity in the treated group. Conclusion: These results suggest that anthracyclines cause impaired endothelial function, an important and newly recognized toxicity. Since endothelial dysfunction is an early event in atherogenesis, there may be important clinical implications from these findings. Further study is required to confirm these preliminary results in a larger cohort.Keywords
This publication has 26 references indexed in Scilit:
- Chronic effect of doxorubicin on vascular endothelium assessed by organ culture studyLife Sciences, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery diseaseThe American Journal of Cardiology, 1996
- Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young AdultsNew England Journal of Medicine, 1996
- Arterial reactivity is significantly impaired in normotensive young adults after successful repair of aortic coarctation in childhood.Circulation, 1994
- Short and long-term effects of smoking on arterial wall properties in habitual smokersJournal of the American College of Cardiology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991
- Early anthracycline cardiotoxicityAmerican Journal Of Medicine, 1978